{"id":"W2898717093","doi":"10.1001/jamaoncol.2018.4628","title":"Safety and Efficacy of Durvalumab With or Without Tremelimumab in Patients With PD-L1–Low/Negative Recurrent or Metastatic HNSCC","year":2018,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":310,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; National Institute for Health and Care Research","keywords":"Tremelimumab; Durvalumab; Medicine; Internal medicine; Head and neck squamous-cell carcinoma; Tolerability; Oncology; Immunotherapy; Adverse effect; Cancer; Head and neck cancer; Nivolumab; Ipilimumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003381502,0.0002176851,0.0007497742,0.0001716349,0.00005588786,0.00000836715,0.00008500717,0.0001042997,0.0004271466],"category_scores_gemma":[0.0001940454,0.0001145816,0.00003951506,0.0004533385,0.0006617668,0.00009258524,0.00003347273,0.0002029606,0.000005221498],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000320357,"about_ca_system_score_gemma":0.0006628711,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002530923,"about_ca_topic_score_gemma":0.003632761,"domain_scores_codex":[0.9984154,0.0002023527,0.0004742751,0.0003479788,0.0002712812,0.0002887732],"domain_scores_gemma":[0.998706,0.0003772835,0.0003043443,0.00026178,0.0002539226,0.00009661275],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6839135,0.001821576,0.06570114,0.0001625552,0.0005776833,0.00005617364,0.004288066,9.669344e-7,0.000185074,0.00001138811,0.0003068433,0.242975],"study_design_scores_gemma":[0.113006,0.05989755,0.8158235,0.000907859,0.0003147213,0.00008124032,0.0008846591,0.00009561415,0.0008349899,0.000007628005,0.007909201,0.0002370408],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966209,0.0001080643,0.00005701741,0.0006608581,0.000120522,0.001215421,0.00002883072,0.0000198761,0.00116852],"genre_scores_gemma":[0.9958749,0.0001413886,0.002856996,0.0005764759,0.00006775508,0.00003689537,0.00002258253,0.00002878121,0.0003941987],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7501224,"threshold_uncertainty_score":0.4676955,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02132207823139834,"score_gpt":0.3195066670134031,"score_spread":0.2981845887820048,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}